NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In

Advertisement
Advertise with NZME.
Home / World

Covid-19 coronavirus: Extra safety scrutiny planned as vaccine worries grow

By Lauran Neergaard
Other·
14 Oct, 2020 07:42 PM7 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

The first patient enrolled in Pfizer's Covid-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection last May. Photo / AP file

The first patient enrolled in Pfizer's Covid-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection last May. Photo / AP file

Facing public scepticism about rushed Covid-19 vaccines, United States health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital.

A new poll suggests those vaccine fears are growing.

With this week's pause of a second major vaccine study because of an unexplained illness — and repeated tweets from US President Donald Trump that raise the spectre of politics over-riding science — a quarter of Americans say they won't get vaccinated. That's a slight increase from one in five in May.

The poll from AP-NORC Centre for Public Affairs Research found only 46 per cent of Americans want a Covid-19 vaccine and another 29 per cent are unsure.

More striking, while Black Americans have been especially hard-hit by Covid-19, just 22 per cent say they plan to get vaccinated compared with 48 per cent of white Americans, the AP-NORC poll found.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

#COVID19 mortality rate: 0.25-0.5%

Long-term lung damage rate, (hospitalised): 66%

Long-term health problem rate (all cases): 10-15%

Long-term heart problem rate, (hospitalised): 20-30%

Long-term brain problem rate (hospitalised): 30-40%

Still want to take a chance?

— Patrick Galey #BlackLivesMatter (@patrickgaley) October 14, 2020

"I am very concerned about hesitancy regarding Covid vaccine," said Dr William Schaffner, a vaccine specialist at Vanderbilt University who says even the primary care doctors who will need to recommend vaccinations have questions.

"If the politicians would stand back and let the scientific process work, I think we'd all be better off," he added.

The stakes are high: Shunning a Covid-19 shot could derail efforts to end the pandemic — while any surprise safety problems after one hits the market could reverberate into distrust of other routine vaccines.

Advertisement
Advertise with NZME.

To all who have reached out - thank you. Here is my personal experience with COVID-19 :https://t.co/XUysq0KVaY

— Melania Trump (@FLOTUS) October 14, 2020

On top of rigorous final testing in tens of thousands of people, any Covid-19 vaccines cleared for widespread use will get additional safety evaluation as they're rolled out.

Among plans from the Centres for Disease Control and Prevention: Texting early vaccine recipients to check how they're feeling, daily for the first week and then weekly out to six weeks.

Any vaccine before election day is extremely unlikely.

Trump and his campaign are keeping focused on their base, and the base doesn't want to hear about the coronavirus. Even among older adults in Florida https://t.co/KYoVdxzOp5

— BuzzFeed News (@BuzzFeedNews) October 14, 2020

Over Trump's objections, the Food and Drug Administration issued clear safety and effectiveness standards that shots must meet - and Commissioner Stephen Hahn insists career scientists, not politicians, will decide each possible vaccine's fate only after all the evidence is debated at a public meeting.

Dr Anthony Fauci, the top US infectious diseases expert, says that should be reassuring because it means scientists like himself will see all the evidence.

"So the chances of there being secret hanky-panky are almost zero, because everything is going to be transparent," he told AP.

Here are some things to watch as vaccines get closer to the finish line.

With many parts of the U.K. seeing large increases in coronavirus infections and the government imposing local restrictions, there are concerns that unemployment could soar towards 3 million, levels not seen since the early 1990s. https://t.co/ECioh6J7a2

— ABC News (@ABC) October 14, 2020

THERE'S STILL NO GUARANTEE

Furthest along in final-stage testing in the US are a vaccine candidate made by Pfizer Inc. and Germany's BioNTech, and another developed by Moderna Inc. and the National Institutes of Health.

Fauci says "the best bet" is that data about whether one or both work will emerge sometime in November or December.

Advertisement
Advertise with NZME.

How soon depends on an independent Data Safety and Monitoring Board - the only group that can peek at the data before the study's finished. At pre-set time points, the board can analyse the number of infections occurring so far among participants and decide if the study should be stopped early because of strong evidence the vaccine works, or if it's failing, or that it's too soon to know.

55% of Democrats would receive a #coronavirus vaccine when it became available, compared to 48% of Republicans. https://t.co/3PMaedScZx pic.twitter.com/fBg3X95Ten

— Morning Consult (@MorningConsult) October 14, 2020

EFFECTIVENESS IS ONLY HALF THE STORY

The DSMB also watches for side effects. Many vaccines cause temporary side effects like fever, chills and other flu-like symptoms.

Two other vaccine candidates in final-stage testing in the US have been temporarily halted to investigate additional safety questions. Johnson & Johnson paused its study this week after learning of "an unexplained illness" in one participant, and the company expects it will take a few days to learn if the problem is a side effect or a coincidence.

But testing of AstraZeneca's vaccine has been on hold in the US for over a month after news emerged of neurological illnesses in two British participants. Regulators let AstraZeneca's study resume in Britain and several other countries, but FDA still is deciding.

Stopping those studies "shows you that the system that we have in place to monitor the safety of the vaccines and the rigorous conduct of the trial is in place and it's working," Schaffner said.

Advertisement
Advertise with NZME.

Looking back at vaccines for other diseases, side effects show up within two to three months, said FDA vaccine chief Dr Peter Marks.

So FDA told Covid-19 vaccine makers: If they seek "emergency use authorisation" to get their shot to market faster than normal, they still would have to track half the participants for two months after the last dose.

Then it would take FDA several weeks of breakneck work to decide if a Covid-19 vaccine really was suitable for emergency use, Marks said. In contrast, evaluating an application for full approval could take months, as FDA officials comb through fuller records of how participants fared.

We expect to see companies pause and look carefully if a potential issue arises, so it's encouraging they're taking safety seriously. https://t.co/mbmWYd5WIN

— Dr. Tom Frieden (@DrTomFrieden) October 14, 2020

EXTRA SAFETY STEPS

Even large final tests won't catch a side effect that happens in, say, one in 100,000 people. So there's an early warning system that monitors every vaccine sold in the US to spot unsuspected side effects.

"It's a system that has served us very well," said Dr Bruce Gellin of the Sabin Vaccine Institute, who once directed the government's National Vaccine Programme Office. "But for this unprecedented vaccination campaign, we need to expand" that monitoring.

Advertisement
Advertise with NZME.

Once the FDA clears a vaccine, health workers and other essential workers are expected to get the first doses — and they'll have to sign an agreement to do so that includes their cell number and email. The CDC will use those registrations to check how the vaccinated are feeling.

Any health complaint bad enough that they missed work, couldn't do a normal activity or had to seek medical care gets a follow-up probe, said CDC's Dr Tom Shimabukuro.

Separately, the FDA will be checking giant databases of insurance claims and electronic medical records, to see if people who received vaccine also have an uptick in health care.

And states including New York, Rhode Island and Virginia are forming advisory committees to review the safety of any Covid-19 vaccines that pass FDA.

- AP

Save

    Share this article

Latest from World

World

'Shop local': Puerto Rico's local hero brings tourism surge

Premium
World

China tests the waters of how far its navy can operate

World

Blaze at Iraqi shopping centre claims 50-plus victims, injures dozens


Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

Advertisement
Advertise with NZME.

Latest from World

'Shop local': Puerto Rico's local hero brings tourism surge
World

'Shop local': Puerto Rico's local hero brings tourism surge

Bad Bunny has started a 30-show concert series in San Juan, drawing fans from everywhere.

17 Jul 05:00 PM
Premium
Premium
China tests the waters of how far its navy can operate
World

China tests the waters of how far its navy can operate

17 Jul 05:00 PM
Blaze at Iraqi shopping centre claims 50-plus victims, injures dozens
World

Blaze at Iraqi shopping centre claims 50-plus victims, injures dozens

17 Jul 07:53 AM


Solar bat monitors uncover secrets of Auckland’s night sky
Sponsored

Solar bat monitors uncover secrets of Auckland’s night sky

06 Jul 09:47 PM
NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP